{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:49Z","timestamp":1791247009700,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jchf.2024.11.007","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:06:51Z","timestamp":1738764411000},"page":"467-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Outcomes of KDIGO-Defined CKD in U.S.\u00a0Veterans With HFpEF, HFmrEF, and\u00a0HFrEF"],"prefix":"10.1016","volume":"13","author":[{"given":"Samir","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh K.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Faselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8093","authenticated-orcid":false,"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiya A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Deedwania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Rangaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Sheriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zeng-Treitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-2024","authenticated-orcid":false,"given":"Wen-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.11.007_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchf.2021.12.005","article-title":"Renal compression in heart failure: the renal tamponade hypothesis","volume":"10","author":"Boorsma","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archinte.166.13.1396","article-title":"Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition study","volume":"166","author":"Bibbins-Domingo","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hfc.2008.03.008","article-title":"Epidemiology of chronic kidney disease in heart failure","volume":"4","author":"Ahmed","year":"2008","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jchf.2024.11.007_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000328905","article-title":"Relationship between stage of kidney disease and incident heart failure in older adults","volume":"34","author":"Bowling","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jchf.2024.11.007_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2021.05.002","article-title":"Kidney function and outcomes in patients hospitalized with heart failure","volume":"78","author":"Patel","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ndt\/gfn445","article-title":"Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study","volume":"24","author":"Campbell","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jchf.2024.11.007_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","article-title":"Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jacc.2004.07.040","article-title":"Renal insufficiency as an independent predictor of mortality among women with heart failure","volume":"44","author":"Bibbins-Domingo","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.11.007_bib12","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2024.11.007_bib13","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jchf.2024.11.007_bib14","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2024.11.007_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2024.11.007_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2024.11.007_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ejhf.3210","article-title":"Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. veterans with heart failure","volume":"26","author":"Patel","year":"2024","journal-title":"Euro J Heart Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib19","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jacc.2023.03.390","article-title":"Efficacy of empagliflozin in patients with heart failure across kidney risk categories","volume":"81","author":"Butler","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib20","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.11.007_bib22","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jacc.2021.08.025","article-title":"Eligibility for SGLT2 inhibitors in heart failure without the race coefficient for kidney function estimation","volume":"78","author":"Rangaswami","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib23","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jchf.2024.11.007_bib24","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/ehf2.14787","article-title":"Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record","volume":"11","author":"Shao","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/amiajnl-2011-000535","article-title":"Automated extraction of ejection fraction for quality measurement using regular expressions in unstructured information management architecture (UIMA) for heart failure","volume":"19","author":"Garvin","year":"2012","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jchf.2024.11.007_bib26","unstructured":"Arnold N. VHA death ascertainment file (DAF) and other data sources for mortality ascertainment. Accessed January 1, 2025. https:\/\/www.hsrd.research.va.gov\/for_researchers\/cyber_seminars\/archives\/video_archive.cfm?SessionID=6303"},{"key":"10.1016\/j.jchf.2024.11.007_bib27","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib28","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.11.007_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2024.11.007_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","article-title":"Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction","volume":"296","author":"Vergaro","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure","volume":"20","author":"Schlaich","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2024.11.007_bib32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.11.007_bib33","series-title":"Cardiorenal Syndrome: Mechanisms, Risk and Treatment","first-page":"279","article-title":"Role of neurohormonal activation in the pathogenesis of cardiovascular complications in chronic kidney disease","author":"Stella","year":"2010"},{"key":"10.1016\/j.jchf.2024.11.007_bib34","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2215\/CJN.03760416","article-title":"Decisions about renal replacement therapy in patients with advanced kidney disease in the US Department of Veterans Affairs, 2000-2011","volume":"11","author":"Wong","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2024.11.007_bib35","series-title":"2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States","year":"2021"},{"key":"10.1016\/j.jchf.2024.11.007_bib36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","article-title":"Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF","volume":"168","author":"Fonarow","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.11.007_bib38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.11.007_bib39","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib44","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2006121372","article-title":"Renoprotection of optimal antiproteinuric doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency","volume":"18","author":"Hou","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2024.11.007_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226509","article-title":"Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: the northern Manhattan study","volume":"15","author":"Willey","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2024.11.007_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100600","article-title":"Estimated GFR with cystatin c and creatinine in clinical practice: a retrospective cohort study","volume":"5","author":"Gottlieb","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.38300","article-title":"Assessment of cystatin C level for risk stratification in adults with chronic kidney disease","volume":"5","author":"Lees","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2024.11.007_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/eurjhf\/hft128","article-title":"The chronic kidney disease epidemiology collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure","volume":"16","author":"Valente","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.11.007_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjmed.2011.10.013","article-title":"Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease","volume":"125","author":"Ahmed","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.amjmed.2023.03.017","article-title":"Renin-angiotensin inhibition and outcomes in HFrEF and advanced kidney disease","volume":"136","author":"Patel","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjmed.2012.06.031","article-title":"Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease","volume":"126","author":"Ahmed","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2024.11.007_bib52","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924008709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924008709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:47:55Z","timestamp":1772336875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924008709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213177924008709"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.11.007","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of KDIGO-Defined CKD in U.S.\u00a0Veterans With HFpEF, HFmrEF, and\u00a0HFrEF","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the The Authors","name":"copyright","label":"Copyright"}]}}